ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GDR Genedrive Plc

2.25
0.00 (0.00%)
28 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.25 2.20 2.30 2.25 2.25 2.25 1,451,687 07:48:42
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0095 -2.37 12.22M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 2.25p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 11.85p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £12.22 million. Genedrive has a price to earnings ratio (PE ratio) of -2.37.

Genedrive Share Discussion Threads

Showing 31876 to 31891 of 33675 messages
Chat Pages: Latest  1287  1286  1285  1284  1283  1282  1281  1280  1279  1278  1277  1276  Older
DateSubjectAuthorDiscuss
09/9/2024
18:40
Tomorrow it could test 2p again

I don't think there will be sales news anytime soon.

I mean, GDR have just started to put together a marketing team.

batiatus
09/9/2024
18:35
It's obviously Achilles have bought in and is hurting from the stock's bad performance.

Should have done more research instead of taking his anger out on users on a bulletin board.

Really shows his character, not as hard as he thinks.

Achilles, let me remind you the company's burn rate is £400K per month.

Money will run out soon. Expect a placing.

batiatus
09/9/2024
18:12
"I'm less depressed than I was!"

That's not a good thing.

Why are you feeling depressed if you're so confident in GDR...

Or is it that you're not confident...

batiatus
09/9/2024
17:43
A full update from the company will calm a few nervous investors both here and on LSE
saad112
09/9/2024
15:57
Seems to me they are building out the structure of a viable business and scaling up to meet the expected demand..All very promising! I'm less depressed than I was !
clem h fandango
09/9/2024
15:56
Excellent what good timing Saad!
hazl
09/9/2024
15:35
and as already pointed out on LSE - it does not say that she is heading up the team

roger65 does not seem to understand what a business development executive role is

chatchat
09/9/2024
15:26
A really good appointment:
saad112
09/9/2024
15:25
You too Patrick!



Patrick Breen
Business Development Director at Genedrive

Patrick Breen has extensive experience in the healthcare and diagnostics industry. Patrick is currently the Business Development Director at Genedrive, where they are responsible for commercializing innovative point-of-care pharmacogenetic tests. Prior to this, they served as the Chief Commercial Officer at MicrosensDx, where they led and developed the molecular diagnostics commercial function.

Before joining MicrosensDx, Patrick worked at Omega Diagnostics Group as the Marketing Director, where they developed and implemented the marketing strategy for Allergy and Health & Wellbeing. Additionally, they held the role of Global Product Manager/Regional Sales Director, where they managed the product plan for the Allergy line and delivered the sales plan for Latin America.
Patrick's earlier experience includes roles at Phadia AB as an Area Manager and at Intercytex Ltd, where they served as a Product Specialist, Production Manager, and Senior Associate Scientist. Their responsibilities included implementing commercial strategies, managing teams, delivering sales targets, and overseeing product development and clinical trials.

Patrick Breen's education history begins with their studies at The Manchester Metropolitan University, where they pursued a Bachelor of Science (Hons) degree in Biological Sciences from 2000 to 2003. Following this, they enrolled in the University of Liverpool from 2006 to 2009 and obtained a Master of Business Administration (MBA) degree, with a specialization in Business Administration

hazl
09/9/2024
15:20
Come on Claire!
We are counting on you.

hazl
09/9/2024
15:17
Interesting.
hazl
09/9/2024
15:08
As i was telling that troll JH there is very STRONG BUYING support @ 2.25p.

Shares will rebound very STRONGLY on any NEWS which is due very soon.

z1co
09/9/2024
15:08
Confirmed Z1co and his team were talking B S!

When they said Dr Gino were the man to bring in sales contracts...

Attempted to ramp Gino as a more suitable CEO ignoring the fact that Cheek had left with no good reason.

There you have it.

Looks like there WON'T be any sales contracts any time soon as they have only just recruited someone for that position

batiatus
09/9/2024
14:51
A post from roger65 on LSE:

"Omg they’ve hired a recent graduate to head up their business development. J3sus. You just cdnt make it up. Wtf is wrong with senior mngt that they can’t see this girl, no matter how clever and talented she may be, will have precisely zero experience and precisely zero contacts within the industry. Starting from scratch. This is the person who will be responsible for coming up with a strategy to sell their products. Didn’t sound like she’s arriving in to an up and running slick sales department. Oh dear oh dear."

batiatus
09/9/2024
14:26
Indeed hazl , orders will start to flow the tests are world class.
It's only a matter of time, we could even get an announcement this week who knows.

Buy and hold for the next 1 to 2 years

saad112
09/9/2024
13:56
An intern here, an intern there

Money here, and money there

These guys sure knows how to blow cash

£400K monthly burn!!!

batiatus
Chat Pages: Latest  1287  1286  1285  1284  1283  1282  1281  1280  1279  1278  1277  1276  Older

Your Recent History

Delayed Upgrade Clock